Filing Details
- Accession Number:
- 0001179110-17-011774
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-23 17:36:29
- Reporting Period:
- 2017-08-21
- Accepted Time:
- 2017-08-23 16:36:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-21 | 2,058 | $15.06 | 269,231 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-21 | 2,058 | $15.07 | 267,173 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2014.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2015.
- This transaction was executed in multiple trades at prices ranging from $14.98 to $15.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $15.00 to $15.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
